Activated protein C alters inflammation and protects renal function in sepsis

J Surg Res. 2011 Jun 1;168(1):e103-9. doi: 10.1016/j.jss.2011.01.008. Epub 2011 Feb 2.

Abstract

Background: Activated protein C (aPC) confers survival benefit in patients with sepsis, yet its protective mechanism(s) remain unclear. Herein, we determined time-dependent severity of renal dysfunction during polymicrobial sepsis. We hypothesized aPC restores renal function by preserving organ architecture and reducing inflammation.

Materials and methods: Sprague-Dawley rats underwent sham operation or cecal ligation and puncture (CLP). At 6 or 24 h post-surgery, kidney function was assessed by plasma electrolytes, blood urea nitrogen (BUN), and creatinine levels. Renal architecture was examined histologically. In the next series of experiments, 24-h post-surgery, animals were treated with vehicle or aPC (1 mg/kg) for 4 d, and kidney function and circulating cytokine levels were measured. Plasma was collected and assayed for BUN, creatinine, and lactate dehydrogenase (LDH) levels. Serum cytokine levels were measured by ELISA.

Results: Plasma electrolytes, BUN, creatinine, and renal architecture were altered 6 h after CLP. Treatment with aPC significantly inhibited sepsis-induced elevations in BUN, creatinine, LDH levels, and improved renal architecture. After CLP, interferon gamma (INFγ) decreased, while interleukins-1beta and -10 (IL-1β and IL-10) increased; these effects were attenuated by aPC treatment.

Conclusions: Our data demonstrate that renal dysfunction occurs as early as 6 h following sepsis and continues thereafter. Treatment with aPC attenuated INFγ and IL-1β changes, and preserved renal function in sepsis. These data suggest aPC may confer a survival advantage by reducing systemic inflammation and, in doing so, preserving organ function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Blood Urea Nitrogen
  • Cecum / injuries
  • Creatinine / blood
  • Disease Models, Animal
  • Infusions, Intravenous
  • Interferon-gamma / blood
  • Interleukin-10 / blood
  • Interleukin-1beta / blood
  • Kidney / drug effects
  • Kidney / pathology
  • Kidney / physiopathology*
  • Ligation / adverse effects
  • Male
  • Nephritis / metabolism
  • Nephritis / physiopathology*
  • Nephritis / prevention & control*
  • Protein C / administration & dosage
  • Protein C / pharmacology
  • Protein C / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis / complications*
  • Sepsis / etiology
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Interleukin-1beta
  • Protein C
  • Interleukin-10
  • Interferon-gamma
  • Creatinine